Navigation Links
Broad-Spectrum Cervical Cancer Vaccine Shows Promise
Date:5/26/2009

Tests in animals get good results against more types of HPV, study finds

TUESDAY, May 26 (HealthDay News) -- An investigational broad-spectrum cervical cancer vaccine induced strong immune responses in mice and rabbits, and protected them against human papillomavirus (HPV) type 16 for four months, new research has found.

Current HPV L1-based vaccines provide almost 100 percent protection against the two types of HPV that cause 70 percent of all cervical cancer cases worldwide, but they are expensive and offer only limited protection against other HPV types that cause cancer, according to the researchers. The new vaccine may help cover that gap in protection, they noted.

When the candidate vaccine was used with a substance such as alum to stimulate immune response, the animals were protected against infection by HPV type 16, the study found.

"Clinical studies are warranted" to assess the safety of these types of vaccines, wrote Richard Roden, of the Johns Hopkins University in Baltimore, and colleagues. If this new type of vaccine proves effective, "its simpler manufacturing process could make the local production of such a vaccine highly feasible, which might achieve the goal of producing it at sustainable prices in emerging countries and lead to its widespread implementation in the developing world," the researchers said.

The study appears online Tuesday in the Journal of the National Cancer Institute.

A broad-spectrum HPV vaccine could solve the shortcomings of current vaccines -- they're too expensive to be used in much of the world and they don't protect against enough HPV types -- Dr. F. Xavier Bosch, of the Catalan Institute of Oncology in Barcelona, Spain, wrote in an accompanying editorial.

The results of this study "open the door to a novel family of second generation HPV vaccines with significant potential value in the public health horizon. As soon as appropriate, Pha
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. A Broad-Spectrum Antibiotic with Activity Against MRSA and Pseudomonas Aeruginosa Would Earn a Higher Patient Share in the U.S. than in Europe for the Treatment of Hospital-Acquired Pneumonia
2. Life Spine(R) Announces Nationwide Market Introduction of KINETIC(R)-SL Dynamic Anterior Cervical Plating System
3. Women with previous abnormal cervical cells at higher risk for recurrence and invasive cancer
4. Dont Lower Age for Cervical Cancer Test, Study Urges
5. NuVasive Announces Acquisition of Cervical Total Disc Replacement Device
6. Womens Health Advocates To Moms: We Can Beat Cervical Cancer!
7. Human papillomavirus genotype distribution in New Mexico cervical cancers
8. Womens Integrative Health Encinitas OB/GYN Selects LUMA Cervical Imaging System
9. MRI and PET/CT improve cervical cancer patients chances for optimal treatment
10. Incidence rates of cervical cancer linked to deprivation
11. LUMA Cervical Imaging System Installed in Edina at Minnesota Gynecology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Broad-Spectrum Cervical Cancer Vaccine Shows Promise
(Date:2/28/2015)... 2015 India Network Foundation, ... health insurance programs for visitors coming to the United ... parents traveling to the United States are suffering from ... blood pressure. These diseases are so common among the ... as medical conditions. There were 66.8 million cases of ...
(Date:2/28/2015)... 28, 2015 Kaylie Corrigan, Outdoor Supervisor ... center , and current student obtaining her Masters degree ... a weekly forum in psychoeducation on substance use for ... AZ as part of her studies. , “Even though ... support and counseling at the high school and junior ...
(Date:2/28/2015)... 28, 2015 On Thursday, February 26th, Forbes ... Easy For Scammers To Steal Your Data , which stresses ... hands on a DIY phishing kit, or any kind of ... on another important point about how everyone’s cyber security is ... implemented, “like compromising legitimate content management systems or blogs in ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The noted ... of Facial Surgery was recently featured in the January/February ... the magazine, Dr. David Ellis was featured in an ... the various cosmetic enhancements that Kim Cattrall has possibly ... , “Her forehead is smooth without horizontal lines or ...
(Date:2/28/2015)... Janesville, WI (PRWEB) February 28, 2015 ... The designation recognizes Mercy Harvard Hospital as stroke capable ... to be brought via ambulance to Mercy Harvard Hospital. ... the state to indicate their ability to treat stroke ... The designation allows ambulances transporting stroke patients to bypass ...
Breaking Medicine News(10 mins):Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Dr. David Ellis Featured In Elevate Magazine 2Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2
... 6 (HealthDay News) -- A gene mutation that helps clear ... they don,t know if people with this mutation have a ... Researchers in the Netherlands studied two families with unusually high ... a type of fat that circulates in the blood. Genetic ...
... WINSTON-SALEM, N.C. -- Breast cancer is on the rise and ... than 65, but very few of them choose to have ... Medical Center sought to determine if breast reconstruction after mastectomy ... "The removal of a breast has implications for the psychological, ...
... Even when surgical tumor removal is combined with a heavy ... cancer will not return. Now researchers at Tel Aviv University ... and an immunity to the cancer,s return with ... "tumor ablation" a process through which the tumor is destroyed ...
... ( Marmota marmota ) live in extended family groups ... of a dominant territorial pair and a number of ... Over a 14-year period, Klaus Hacklnder of the Institute ... Resources and Life Sciences, Vienna and Walter Arnold of ...
... arterial injury, the inner layer of cells in the artery ... more harm than good", says Maria Gomez. A common ... often performed on patients who have had a heart attack. ... while new cell formation increases the risk of further heart ...
... Breast reconstruction surgery will become both safer and more ... Technology (QUT) in Brisbane, Australia. Professor Dietmar W. ... (IHBI) recently conducted a research project in collaboration with ... computer aided design (CAD) to produce moulds accurately modelled ...
Cached Medicine News:Health News:Gene Mutation Helps Clear Fats From Blood, Study Finds 2Health News:Advanced age should not deter women from breast reconstruction after cancer 2Health News:Blasting cancer from the inside out 2Health News:Blasting cancer from the inside out 3Health News:Hanging with the boys - female Alpine marmots benefit from a bit of pre-natal testosterone 2Health News:Stopping dangerous cell regrowth reduces risk of further heart attacks 2Health News:Research advances breast reconstruction 2
(Date:2/27/2015)... , February 27, 2015 ... bahnbrechendes Überwachungssystem für kongestive Herzinsuffizienz (CHF) in ...     ... ein neuartiges Herzüberwachungssystem für Patienten mit kongestiver ... dass sie ein Finanzierungsvorhaben über 5 Mio. ...
(Date:2/27/2015)... JERUSALEM , Feb. 27, 2015  Chiasma, Inc., ... lead product for the orphan condition acromegaly, today announced ... round. Participants in the financing included new investors Rock ... chip public investment fund, as well as existing investors ... and ARCH Venture Partners. Chiasma intends ...
(Date:2/26/2015)... February 27, 2015 RnRMarketResearch.com ... market research report to its store. This report ... therapeutic pipeline. The report "Corneal Ulcers - Pipeline ... therapeutic development for Corneal Ulcers. Corneal Ulcers are ... bacterial infections, viral infections & fungal infections. The ...
Breaking Medicine Technology:Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Chiasma Announces Completion of $70 Million Series E Financing 2Chiasma Announces Completion of $70 Million Series E Financing 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5
... Heart, Inc. today announced that NewYork-Presbyterian Hospital/ Columbia ... U.S. center, and first in the Northeast, to ... of the DuraHeart Bridge-To-Transplant U.S. pivotal trial, a ... up to 40 centers nationwide. The trial ...
... 7 NovaBay Pharmaceuticals, Inc. (NYSE Alternext: ... novel, synthetic anti-infective products for the treatment ... bacterial, fungal, and viral infections without developing ... that NVC-422, the Company,s lead Aganocide(R) compound, ...
Cached Medicine Technology:Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient 2Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient 3NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection 2NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection 3NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: